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Abstract
Introduction. The aim of this experiment was to study the effects of the antioxidant drug “U-74389G” 
on rat model, particularly in ischemia reperfusion protocol. The beneficial or other effects of that molecule 
were studied estimating the mean endosalpingeal karyorrhexis (EK) lesions. 
Material and methods. 40 rats were used of mean weight 247.7 g. EK was evaluated 60 min after 
reperfusion for groups A and C and 120 min after reperfusion for groups B and D. Groups A and B without 
the drug but C and D with erythropoietin administration.
Results. Results were that erythropoietin administration kept non-significantly increased the EK scores 
by 0.1 (–0.0393284–0.2393284) (p = 0.1544). This finding was in accordance with the results of 
Wilcoxon signed-rank test (p = 0.1573). Reperfusion time non-significantly decreased the EK scores by 
0.1 (–0.2393284–0.0393284) (p = 0.1544), approximately in accordance with the increased EK score by 
0.1 (–0.2440518–0.0440518) of Wilcoxon signed-rank test (p = 0.1573). However, Epo administration 
and reperfusion time together kept non-significantly increased the EK scores by 0.0181818 (–0.0679319– 
–0.1042955) (p = 0.6715). 
Conclusions. Results of this study indicate that Epo administration kept non-significantly increased the 
EK scores. Perhaps, a longer study time than 2 hours may provide more significant effects. 
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Introduction
Tissue ischemia and reperfusion (IR) remain one 
of the main causes of permanent or transient dam-
age with serious implications on adjacent organs and 
certainly on patients’ health. The use of erythropoi-
etin (Epo) is a well-established knowledge for many 
years. However, despite important progress has been 
made, satisfactory answers have not been obtained yet 
to the fundamental questions, such as, by what velocity 
this factor acts, when it should be administered, and in 
what dosage. The particularly satisfactory action of the 
erythropoietin in stem blood cells recovery has been 
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noted in several performed experiments. Since a careful 
literature search (PubMed — Medline) was conducted, 
it was realized that this certain factor has been tried in 
experiments. However, just few relative reports were 
found, not covering completely this particular object of 
action velocity. A lot of publications are present on trials 
of other similar molecules of growth factors to which 
the studied molecule also belongs to. 
The aim of this experimental study was to examine 
the effect of the drug erythropoietin on rat model and 
particularly in an oviducts IR protocol. The beneficial ef-
fect or non-effectiveness of that molecule were studied 
by evaluating endosalpingeal karyorrhexis (EK). 
Material and methods
Animal preparation
This experimental study was approved by Scientific 
Committee of Ippokrateion General Hospital, Athens 
University and by Veterinary Address of East Attiki Pre-
fecture under 3693/12–11–2010 & 14/10–1–2012 de-
cisions. Institutional and national guide for the care 
and use of laboratory animals was followed. This ex-
perimental study was carried out at the Exprerimental 
Research Center of ELPEN Pharmaceuticals Co. Inc. 
S.A. at Pikermi, Attiki. All settings needed for the study 
including of consumables, equipment and substances 
used, were provided by them. Albino female Wistar 
rats were used in accordance with accepted standards 
of humane animal care. They spent 7 days in laboratory 
before experimentation with easy access to water and 
food. The experiment was acute, that is, the animal 
usage was completed by following experimental set 
of times without awakening and preservation of the 
rodents. They were randomly assigned to four experi-
mental groups (10 animals in each group):
— group A: ischemia for 45 min followed by reperfu-
sion for 60 min;
— group B: ischemia for 45 min followed by reperfu-
sion for 120 min;
— group C: ischemia for 45 min followed immediately 
by Epo intravenous (IV) administration and reperfu-
sion for 60 min;
— group D: ischemia for 45 min followed immedia-
tely by Epo IV administration and reperfusion for 
120 min.
The molecule erythropoietin was administered in 
a dose of: 10 mg/kg body weight of the animal. The 
experiment was beginning by prenarcosis and general 
anesthesia administration to the animals. Their electro-
cardiogram and acidometry were continuously moni-
tored. The inferior aorta was prepared so as its blood 
flow could be excluded by forceps. After exclusion, 
the protocol of IR was applied, exactly as is described 
in experimental groups. The molecules were adminis-
tered at the time of reperfusion, through inferior vena 
cava catheterization, which had been carried out after 
general anesthesia. The EK evaluation was performed 
at 60 min after reperfusion for groups A and C and at 
120 min after reperfusion for groups B and D.
Protocol of the experiment
The experimental rats were given general anes-
thesia by initial intramuscular (IM) administration of 
0.5 cc of a compound, constituting 0.25 cc xylazine, 
(25 cc, 20 mg/cc) and 0.25 cc ketamine hydrochloride 
(1000, 100 mg/cc, 10cc). 0.03 cc butorphanol (10 mg/cc, 
10cc) anesthetic agent was administered subcutane-
ously (SC) before laparotomy. Continuous oxygen sup-
ply was administered during the whole experiment. 
Ischemia was caused by clamping inferior aorta over 
renal arteries for 45 min after laparotomic access. Rep-
erfusion was achieved by removing the clamp and infe-
rior aorta patency re-establishment. Forty (40) female 
Wistar albino rats were used of mean weight 247.7 g 
(SD = 34.99172 g), with min weight ≥ 165 g and max 
weight £ 320 g. Rats’ weight could be potentially a con-
fusing factor, for example fatter rats to have greater EK 
counts. This suspicion will be investigated. Also, detailed 
histopathological study [1] (pathology) and grading of EK 
findings was performed by scores, this is: 0 when lesions 
were not found, 1 when mild lesions were found, 2 when 
moderate lesions were found and 3 when serious lesions 
were found. The previous grading is transformed as fol-
lows: (0–0.499) without lesions, (0.5–1.499) the mild 
lesions (1.5–2.499), the moderate lesions and (2.5–3) 
the serious lesions damage, because the study concerns 
score ranges rather than point scores.
Model of ischemia-reperfusion injury
Control groups
20 control rats of mean weight 252.5 g (SD = 
= 39.31988 g) were subjected to ischemia for 45 min 
followed by reperfusion.
Group A
10 controls rats of mean weight 243 g (SD = 
= 45.77724 g), mean without lesions EK score 0 (SD = 0) 
were subjected to 60 min reperfusion (tab. 1).
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Group B
10 controls rats of mean weight 262 g (SD = 
= 31.10913 g) mean without lesions EK score 0 (SD = 0) 
were subjected to 120 min reperfusion (tab. 1). 
Erythropoietin group
20 rats of mean weight 242.9 g (SD = 30.3105 g) 
were subjected to ischemia for 45 min followed by 
reperfusion in the beginning of which 10 mg Epo/kg 
body weight were IV administered. 
Group C
10 Epo rats of mean weight 242.8 g (SD = 
= 29.33636 g), mean mild EK score 0.2 (SD = 0.421637) 
were subjected to 60 min reperfusion (tab. 2). 
Group D
10 Epo rats of mean weight 243 g (SD = 32.84644 g), 
mean without lesions EK score 0 (SD = 0) were sub-
jected to 120 min reperfusion (tab. 3). 
Results
Every rats’ weight group initially was compared with 
each one from 3 remained groups applying statistical 
paired t-test. (tab. 2). Any emerging significant differ-
ence among EK scores will be investigated whether 
owed in the above mentioned significant weight cor-
relations. Every EK scores rats group initially was com-
pared with other one from 3 remained groups applying 
Wilcoxon signed-rank test (tab. 2). Applying generalized 
linear models (glm) with dependant variable the EK 
scores and independent variables the Epo administra-
tion or no, the reperfusion time and their interaction, 
resulted in: Epo administration kept non-significantly in-
creased the EK scores by 0.1 (–0.0393284 – 0.2393284) 
(p = 0.1544). This finding was in accordance with the 
results of Wilcoxon signed-rank test (p = 0.1573). Rep-
erfusion time non-significantly decreased the EK scores 
by 0.1 (–0.2393284 – 0.0393284) (p = 0.1544), approx-
imately in accordance with the increased EK score by 
0.1 (–0.2440518 – 0.0440518) of Wilcoxon signed-rank 
test (p = 0.1573). However, Epo administration and rep-
erfusion time together kept non-significantly increased 
the EK scores by 0.0181818 (–0.0679319 – 0.1042955) 
(p = 0.6715). Reviewing the above and table 2, table 3 
sums up concerning the decreasing influence of Epo 
in connection with reperfusion time. Inserting the rats 
weight as independent variable at glm, a non significant 
relation turns on (p = 0.5477), so as to further inves-
tigation is not needed.
Discussion
The following clinical situations show the associa-
tion between ischemia and EK. Isik et al. [2] found 
lower karyorrhexis in local treatment with antithrom-
bin in hepatic ischemia-reperfusion injury group. Taki-
Table 1. Weight and endosalpingeal karyorrhexis score 
mean levels and standard deviation of groups 
Groups Variable Mean SD
A Weight 243 g 45.77724 g
EK Without lesions 0 0
B Weight 262 g 31.10913 g
EK Without lesions 0 0
C Weight 242.8 g 29.33636 g
EK Without lesions 0.2 0.421637
D Weight 243 g 32.84644 g
EK Without lesions 0 0
SD — standart deviation; EK — endosalpingeal karyorrhexis
Table 2. Statistical significance of mean values difference for 
groups after statistical paired t-test application for weight 
and Wilcoxon signed-rank test for scores
DG Variable Difference p-value
A-B Weight –19 g 0.2423 
 EK Without lesions 0 1.0000 
A-C Weight 0.2 g 0.9900 
EK Without lesions –0.2 0.1573 
A-D Weight 0 g 1.0000 
 EK Without lesions 0 1.00001 
B-C Weight 19.2 g 0.2598 
 EK Without lesions –0.2 0.1573 
B-D Weight 19 g 0.1011 
EK Without lesions 0 1.0000 
C-D Weight –0.2 g 0.9883 
 EK Without lesions 0.2 0.1573 
DG — difference for groups; EK — endosalpingeal karyorrhexis
Table 3. The increasing influence of erythropoietin in 
connection with reperfusion time
Increase 95%  
c. in.
Reperfusion 
time
p-values
Wilcoxon glm
Without lesions –0.2 –0.0801229– 
–0.4801229
1 h 0.1573 0.1510 
Without lesions –0.1 –0.0393284– 
–0.2393284
1.5 h 0.1573 0.1544
Without lesions 0 Undefined 2 h 1.0000 1.0000
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zawa et al. [3] considered as major cause of neonatal 
hypoxic-ischemic (HI) encephalopathy the oxidative 
stress, which induces DNA peroxidation, apoptotic 
neuronal death and karyorrhexis significantly increased 
after 24–72 h of HI insult. Sun et al. [4] found various 
types of eosinophilic neurons (ENs) in post-ischemic 
gerbils brain. ENs with minimally abnormal nuclei and 
swollen cell bodies appeared at 3 h in the ischemic core 
and at 12 h in the periphery. In the ischemic periphery, 
ENs had slightly atrophic cytoplasm and sequentially 
developed pyknosis, karyorrhexis and karyolysis over 
1 week. Folkerth et al. [5] observed nuclear karyorrhex-
is and/or pyknosis with cytoplasmic hypereosinophilia in 
neurons in the arcuate nucleus in consecutive stillbirth 
brains from 22 to 41 gestational weeks, considering in 
part on hypoxic-ischemic lesions such as white matter 
and brainstem gliosis for the unexplained stillbirth is 
based. Takizawa et al. [6] considered pontosubicular 
neuron necrosis as one of perinatal hypoxic-ischemic 
brain injury and its pathological peculiarity is neuronal 
apoptosis closely associated with presence of karyor-
rhexis. Hargitai et al. [7] associated preterm birth with 
hypoxic-ischemic encephalopathy, including neuronal 
karyorrhexis mostly at the diencephalon and brain stem. 
Hallak et al. [8] caused an increase in the proportion 
of fetal rats that had brain injury, including shrinkage of 
cells and karyorrhexis in the hippocampus and thalamus 
(from 0% to ~ 38.5%; p < 0.05) by hypoxia and de-
creased maternal oxygen tension and pH. Tan et al. [9] 
investigated in utero free radical production and injury 
following hypoxia-ischemia to premature fetal brain 
utilizing a rabbit model of acute placental insufficiency. 
Hypoxia resulted in a significant increase in nitrogen 
oxides, lipid peroxidation, and protein oxidation, with 
a concomitant decrease in total antioxidant capacity, 
compared with controls. Fetuses delivered 24 h post-is-
chemia had increased hippocampal nuclear karyorrhexis 
on histology compared with controls. Meng et al. [10] 
manifested  neuronal karyorrhexis more predominant in 
preterm infants perinatal hypoxic-ischemic basal ganglia 
necrosis. Fortuna et al. [11] developed a model of mildly 
ischemic-hypoxic brain injury consisted of neuronal 
degeneration and necrosis with nuclear pyknosis and 
karyorrhexis. Khera [12] proposed a tentative 3 phase 
sequence of pathogenesis for the embryotoxic action of 
valproic acid (800 mg/kg) administered orally to rats on 
day 13 of pregnancy. In the third or embryonic phase, 
a pleiotropic karyorrhexis in the embryo, appeared 
aggravated, presumably by the preceding labyrinthine 
degeneration of the placental phase. Squier et al. [13] 
examined infant brains who were stillborn or died due 
to cerebral palsy in the early neonatal period. Criteria 
for white matter ischemia were reactive astrocytosis, 
macrophage infiltration, karyorrhexis and endothelial 
swelling or reduplication. Kalimo et al. [14] classified 
caudate nucleus and putamen to selectively vulnerable 
brain regions which incur neuronal damage induced by 
hypoglycemia and ischemia. By day 2–3 of recovery the 
great majority of the medium-sized neurons had under-
gone karyorrhexis and cytorrhexis, their remnants being 
subsequently removed by macrophages. Burton et al. 
[15] showed no evidence of hydatidiform mole (circum-
ferential trophoblastic proliferation, hydrops, scalloped 
villi, and stromal karyorrhexis) in 85% of 25 women 
with a rare suspected tubal ectopic hydatidiform mole. 
Three cases of molar pregnancy (15%) were identi-
fied. Each of these cases had the histological features 
of an early complete hydatidiform mole. Their results 
show that tubal ectopic hydatidiform mole is a rare 
entity and demonstrate that it is over-diagnosed. Samaila 
et al. [16] showed hydatidiform mole characterized by 
circumferential trophoblastic proliferation, hydropic 
degeneration and stromal karyorrhexis in 5 females with 
ectopic ruptured tubal hydatidiform mole gestations.
Also, there is an association between Epo and ovi-
ducts. Lappin [17] supposed that the beneficial effects 
of hEpo are likely to extend to organs such as ovaries, 
oviducts, uterus which have Epo receptors. Sasaki et 
al. [18] claimed that Epo is both estrogen inducible 
and produced in oviducts. Masuda et al. [19] found 
E2-induced stimulation of Epo mRNA in oviductal 
ampulla and isthmus regions, being transient, rapidly 
down-regulated and hypoxia inducible. The E2 action 
is probably mediated through the E2 receptor, and de 
novo protein synthesis is not required for E2 induction 
of Epo mRNA. Ochiai et al. [20] attained the synthesis 
of hEpo protein attempting localized in vivo plasmid 
DNA gene transfer in laying chicken oviducts.
Conclusion 
Results of this study indicate that Epo administration 
kept non-significantly increased the EK scores. Perhaps, 
a longer study time than 2 hours may provide more 
significant effects. 
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